Microcap BioMimetric Therapeutics (BTMI -15.4%) extends steep losses realized AH yesterday...

|By:, SA News Editor

Microcap BioMimetric Therapeutics (BTMI -15.4%) extends steep losses realized AH yesterday following the rejection by the FDA of the firm's bone-graft device. Shares now trade at their lowest level since 2006.